Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of nanocurcumin and chlorhexidine mouthwash on levels of interleukin 1 and 6
IRCT20220223054108N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin and chlorhexidine in None, sponsored by Golestan University of Medical Sciences. Primary endpoints: Change in interleukin-1 levels and Change in interleukin-6 levels. Started Apr 2022; status: completed.
02
Drugs
nanocurcuminchlorhexidine
Beyond the preview
Go deeper on IRCT20220223054108N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220223054108N1.